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ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of
infectious diseases. Mycobacteria have a complex cell envelope containing a pepti-
doglycan layer and an additional arabinogalactan polymer to which a mycolic acid
bilayer is linked; this complex, multilayered cell wall composition (mAGP) is con-
served among all CMN group bacteria. The arabinogalactan and mycolic acid synthe-
sis pathways constitute effective drug targets for tuberculosis treatment. Ethambutol
(EMB), a classical antituberculosis drug, inhibits the synthesis of the arabinose poly-
mer. Although EMB acts bacteriostatically, its underlying molecular mechanism re-
mains unclear. Here, we used Corynebacterium glutamicum and Mycobacterium phlei
as model organisms to study the effects of EMB at the single-cell level. Our results
demonstrate that EMB speciﬁcally blocks apical cell wall synthesis, but not cell divi-
sion, explaining the bacteriostatic effect of EMB. Furthermore, the data suggest that
members of the family Corynebacterineae have two dedicated machineries for cell
elongation (elongasome) and cytokinesis (divisome).
IMPORTANCE Antibiotic treatment of bacterial pathogens has contributed enor-
mously to the increase in human health. Despite the apparent importance of antibi-
otic treatment of bacterial infections, surprisingly little is known about the molecular
functions of antibiotic actions in the bacterial cell. Here, we analyzed the molecular
effects of ethambutol, a ﬁrst-line antibiotic against infections caused by members of
the genus Mycobacterium. We ﬁnd that this drug selectively blocks apical cell
growth but still allows for effective cytokinesis. As a consequence, cells survive
ethambutol treatment and adopt a pneumococcal cell growth mode with cell wall
synthesis only at the site of cell division. However, combined treatment of ethambu-
tol and beta-lactam antibiotics acts synergistically and effectively stops cell prolifera-
tion.
Bacterial antibiotic resistance is an increasing problem in human health and hasgained tremendous attention in recent years (1). The occurrence of multiple-drug
resistance within pathogenic strains has also been described for Mycobacterium tuber-
culosis, the causative agent of tuberculosis (TB) (2). According to a current report by the
World Health Organization, the annual death toll due to TB outnumbers the casualties
due to HIV infection, indicating that TB is among the most dangerous infectious
diseases. An estimated 1.5 million people died from TB infection in 2014, despite the
availability of antibiotic treatment. The bacterial cell wall is a prime target for antibiotic
treatment, as it is essential for growth and survival. Moreover, in mycobacteria, the cell
wall is also required for virulence (3). The cell wall is composed of a complex polymer
that can be divided into three distinct layers (4, 5). Mycobacteria contain a classical
bacterial peptidoglycan (PG) sacculus, which is covalently connected to an arabinoga-
lactan (AG) layer (5–7). The AG polymer is further linked to long-chain mycolic acids
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(MAs) (8, 9). The synthesis pathway of this mycolyl-AG-PG (mAGP) complex has been
extensively studied over the past years, and many reactions and their corresponding
enzymes have been elucidated (4).
Mycobacterium species share this complex cell wall composition with other mem-
bers of the order Actinomycetales, such as Corynebacterium and Nocardia species. This
group of bacteria is therefore also known as the Corynebacterium, Mycobacterium, and
Nocardia (CMN) group or mycolata (10, 11). Corynebacteria are abundant skin com-
mensals and include notorious pathogens such as Corynebacterium diphtheriae. Al-
though the details of the cell wall synthesis pathways are known, the mode of growth
and the subcellular assembly of the corresponding molecular machines driving cell wall
synthesis are poorly characterized (12). This is surprising in light of the fact that several
ﬁrst-line antibiotics used in TB treatment target steps in cell wall synthesis (13).
Ethambutol (EMB) is one of the antibiotics that act speciﬁcally against cell wall synthesis
in CMN group bacteria (14–17). EMB blocks the polymerization of arabinose subunits in
the AG layer of the cell wall (18, 19), which leads to loss of the MA layer. EMB acts
bacteriostatically; however, the precise effects of this drug at the single-cell level have
not been addressed; how cells react to EMB treatment and how cell growth is affected
remain unclear. Here, we used the nonpathogenic model bacteria Corynebacterium
glutamicum and Mycobacterium phlei to unravel the mechanism underlying the action
of EMB. C. glutamicum, in particular, has emerged as an excellent tool for studying
apical growth in bacteria (12).
Previously, we reported on the organization of polar elongation growth in C. glu-
tamicum (20, 21). The polar scaffold protein DivIVA (Wag31 in M. tuberculosis) serves as
the central hub in polar organization through its interaction with the shape, elongation,
division, and sporulation (SEDS) protein RodA and the penicillin-binding protein PBP2A,
thus providing spatial regulation of the polar elongation complex known as the
elongasome (20–23). Recently, it was shown that RodA is a major glycosyltransferase
involved in PG synthesis (24). Moreover, DivIVA is involved in the tethering of chro-
mosome origins through an interaction with ParB (25), thereby coupling the cell cycle
and growth. However, it is unclear where the CMN group-speciﬁc AG and MA layers are
added and whether these bacteria contain dedicated machineries for cell wall synthesis
at the cell poles and at the division site.
Here, we show that EMB-treated cells speciﬁcally arrest cell wall synthesis at the cell
poles; i.e., they speciﬁcally block elongation growth. However, these EMB-treated cells
are still able to form new division septa where new PG is inserted into the cell wall.
Although the arabinose content of the cell wall is clearly reduced and the MA layer is
lost, these cells survive and switch to pneumococcal-type elongation growth by
inserting cell wall material at the division sites. Thus, by maintaining PG synthesis
during cell division, the cells remain viable and return to normal growth following the
termination of EMB treatment. Our data explain the bacteriostatic effect of EMB and
suggest that CMN group bacteria (also termed Corynebacterineae) use two distinct
machineries for the synthesis of their cell wall, a polar elongasome that synthesizes all
three layers of the complex cell wall and a conventional divisome that synthesizes
solely PG during cytokinesis.
RESULTS
EMB has a bacteriostatic effect on C. glutamicum growth. EMB is a cell wall-
acting antibiotic that targets enzymes that are part of the actinobacterial AG synthesis
machinery (19). EMB is most effective against mycobacteria, which require their mAGP
layer for viability. In addition to serving as a ﬁrst-line antibiotic for treating TB, EMB is
also the drug of choice for treating various infections caused by nontuberculous
mycobacteria (NTM) (17). We chose to use C. glutamicum and M. phlei as model
organisms because of their similar cell wall architecture. First, we tested the effect of
EMB on the growth of C. glutamicum by using a ready-made microﬂuidic chamber. To
monitor the growth and synthesis of new septa, we used a C. glutamicum strain
expressing a functional mCherry fusion of the polar growth determinant DivIVA as
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previously described (25). DivIVA-mCherry localizes to the cell poles and maturing septa
by binding to negatively curved membrane regions (25–27). Cells were loaded into the
microﬂuidic chamber, and growth was monitored microscopically. Cells were initially
cultured in brain heart infusion (BHI) medium, and once growth commenced (as judged
by several rounds of division), the growth medium was changed to BHI including EMB
(1 mg · ml1). Cell growth continued in the presence of EMB; however, the growth rate
was decreased and the cells changed from a distinct rod shape to a round, almost
coccoidal shape (Fig. 1). An increase in DivIVA-mCherry ﬂuorescence suggests a de-
crease in elongation growth. DivIVA expression is constitutive during the cell cycle, and
the concentration of the DivIVA protein is diluted by cell growth division events. We
observed a signiﬁcant increase in DivIVA protein levels in the cells upon EMB treatment,
which appeared to be partly mislocalized (Fig. 1). Starting at 5 h following EMB
addition, a hydrophobic material was released from the cell surface, appearing as a
ﬁbrous material surrounding the cells. Chemical analysis indicated that these ﬁbers
consist of MAs (see Fig. S1 in the supplemental material), which are apparently released
from the cell surface. On the basis of these initial ﬁndings, we proceeded with an
in-depth analysis of the activity of EMB against C. glutamicum.
Growth experiments with BHI medium revealed a decrease in growth rates following
the addition of 1 g · ml1 EMB, while higher concentrations of EMB did not further
increase the retardation of growth (Fig. 2A). The exponential doubling time of wild-type
(WT) cells without EMB was 96 min; the addition of EMB increased the doubling time
to 138 min. The ﬁnal optical density at 600 nm (OD600) of the shaking cultures was
reduced from ~10 without EMB to ~6 with EMB. As predicted and in agreement with
the ﬁndings of our microﬂuidic analysis, EMB appears to act bacteriostatically. To
determine how many cells survived EMB treatment, we measured CFU counts.
Exponential-phase cell cultures with and without EMB were adjusted to an OD of 1, and
dilutions were plated on fresh BHI agar plates without EMB (not shown). WT cultures
contained 3.7  108 CFU; the addition of EMB to growing cells resulted in a reduction
to 5  107 CFU, suggesting that EMB does not effectively kill C. glutamicum cells but
rather inhibits growth. Furthermore, we performed live-dead staining of cultures grown
FIG 1 Time-lapse analysis of EMB-treated C. glutamicum cells. C. glutamicum cells encoding a chromo-
somal copy of DivIVA-mCherry (red ﬂuorescence) were grown in ready-made microﬂuidic chambers
(CellAsic). Cells were grown in BHI medium for 1.5 h prior to a switch to BHI medium supplemented with
EMB (1 mg · ml1). Upon the addition of EMB, a morphological transition from long, regularly shaped
rods to short, roundish cells occurred. Note that at 5 h posttreatment, hydrophobic material appearing
as ﬁbers in the phase-contrast images become visible.
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in the presence of 0, 10, or 100 g · ml1 EMB. Fluorescence microscopy revealed that
up to 2% of the cells in untreated cultures were dead. In samples treated with 10
or 100 g · ml1 EMB, up to 5% of the cells were dead (Fig. S2). This low percentage
of dead cells is in line with the notion that EMB acts bacteriostatically on C. glu-
tamicum.
FIG 2 Effect of EMB stress on C. glutamicum cells. (A) Growth curves of WT C. glutamicum cells treated with different
concentrations of EMB. Growth is signiﬁcantly inhibited by EMB at 1 g · ml1. (B) Analysis of cell length with (red bars) or
without (blue bars) EMB treatment. (C) Fluorescence microscopy images of C. glutamicum DivIVA-mCherry cells (strain BSC003)
following treatment with different concentrations of EMB. Morphology appears altered, and cells are shorter and thicker.
Moreover, the DivIVA protein level is increased and the protein is mislocalized. Scale bars, 2 m. (D) Protein quantiﬁcation
following immunoblotting. (Top) Samples of whole-cell extracts from cultures with equal ODs were used for SDS-PAGE and
immunoblotting. DivIVA-mCherry was detected with an anti-mCherry antibody and a secondary antibody coupled to alkaline
phosphatase. The molecular size marker (M) indicates 80 kDa. (Bottom) DivIVA-mCherry cells were fractionated following lysis
by centrifugation and SDS-PAGE. DivIVA-mCherry was detected by in-gel ﬂuorescence. Samples were taken 1, 3, and 5 h after
the addition of EMB (t  1 to t  5). Fluorescence quantiﬁcation of in-gel ﬂuorescence (right diagram) indicates an increase
in the DivIVA protein concentration upon EMB addition. Error bars indicate standard deviations. M, marker; CD, cell debris; CM,
cell membranes; Sol, soluble fraction; AU, arbitrary units. (E) Fluorescence microscopy of C. glutamicum RodA-YFP (strain
BSC026) and FtsW-CFP (strain BSC025) following EMB treatment. RodA is mislocalized, and the protein level seems to increase
upon the addition of EMB. The FtsW protein level appears to be unaffected, and FtsW localization is restricted to septa. (F)
Fluorescence microscopy of DivIVA-mCherry in the exponential and stationary growth phases with or without EMB. EMB
targets and affects the polar elongation machinery. Cells in stationary phase that have no distinctive elongation growth are
not affected by EMB; morphology and the DivIVA level are not altered.
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EMB affects cell morphology. Next, we analyzed the morphological effects of
EMB on C. glutamicum cells by using phase-contrast microscopy. Addition of EMB
(1 g · ml1) to exponentially growing cells resulted in a decrease of approximately
32% in the average cell length, whereas thickness increased to approximately 123%;
following EMB treatment, cell length was reduced to 1  0.25 m, compared to 2 
0.25 m in untreated cells (Fig. 2B). The cell volume was calculated as 1.15  0.64 m3
following EMB treatment, a decrease of approximately 29% compared to that of
untreated WT cells (1.62  0.64 m3). Our data are compatible with previous reports
regarding morphological changes subsequent to EMB treatment (28).
EMB treatment causes accumulation of DivIVA. Having observed morphological
alterations such as shorter and thicker cells and reduced growth rates following EMB
treatment, we next addressed why EMB-treated cells apparently increase cellular DivIVA
levels.
To determine whether DivIVA levels were increased because of upregulated tran-
scription rates, we performed quantitative PCR (qPCR) experiments and compared the
DivIVA mRNA level with those of three different housekeeping genes (thrC [threonine
synthase], gyrB [DNA gyrase], and glnA [glutamine synthetase]). DivIVA mRNA levels,
and thus transcription rates, were not altered upon the addition of EMB (data not
shown). A possible explanation for the increased levels is that the constitutive expres-
sion of DivIVA leads to accumulation upon growth inhibition, similar to the situation in
stationary-phase cells. If transcriptional levels are not altered, it is likely that the protein
levels increase over time because of DivIVA accumulation as a result of reduced
elongation growth.
Therefore, we next quantiﬁed DivIVA-mCherry protein levels. Allelic replacement of
divIVA at the native locus with an mCherry fusion gene allowed precise protein
quantiﬁcation. Immunoblotting with antibodies directed against the mCherry protein
conﬁrmed the increase in DivIVA levels (Fig. 2D, top). As we observed only minor DivIVA
degradation products containing the mCherry fusion on the immunoblots and a
substantial increase in full-length protein, we concluded that the mislocalization of
DivIVA, as seen in the ﬂuorescence micrographs (Fig. 1; Fig. 2C), was due to saturation
of the polar regions with DivIVA and a consequent random distribution of DivIVA within
the whole cell. A cell fractionation study revealed that the increased concentration of
DivIVA-mCherry leads to an enhanced level of membrane-bound DivIVA (Fig. 2D,
bottom). In-gel ﬂuorescence measurements of whole-cell extracts (CD), cell membrane
fractions (CM), and the cytoplasm (Sol) showed that following 1 to 3 h of EMB
treatment, most of the DivIVA is located in the soluble fraction. However, strong
enrichment of DivIVA leads to coisolation of DivIVA with the cell membrane, indicating
that excess DivIVA might bind to the membrane. The ﬂuorescence quantiﬁcation results
also suggest a substantial increase in DivIVA-mCherry in EMB-treated cells (Fig. 2D, right
side). DivIVA-mCherry ﬂuorescence remained unchanged in untreated cells between 1
and 5 h of growth; however, upon EMB treatment, DivIVA-mCherry ﬂuorescence
increased 4-fold.
To analyze whether the excess DivIVA found after EMB treatment caused the
morphological changes seen, we constructed a strain overexpressing DivIVA (GGB1C9).
The plasmid-encoded DivIVA-Dendra2 construct is under the control of an isopropyl-
-D-thiogalactopyranoside (IPTG)-inducible promoter. Overexpression of DivIVA can be
monitored by measuring Dendra2 ﬂuorescence. Cells overexpressing DivIVA have a
slightly lower growth rate (Fig. S3A) than the WT. Interestingly, cells overexpressing
DivIVA are more susceptible to EMB addition. The excess DivIVA-Dendra2 localizes to
the poles of untreated cells (Fig. S3B). In untreated cells, DivIVA overexpression causes
polar bulging and the morphology of the cells is usually wider with increased cell poles
(Fig. S3B). Upon EMB addition, DivIVA accumulates at the cell poles, causing massive
shape aberrations. These data suggest that an EMB-caused block of polar growth acts
through DivIVA.
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EMB treatment causes mislocalization of the apical growth machinery. The
observed reduction in cell elongation growth points to a block in cell elongation.
Although the precise composition of the apical cell growth machinery is unclear, we
have previously shown that the SEDS protein RodA is an essential part of the cell
elongation machinery (20, 21). Therefore, we used a strain in which the native rodA
gene was replaced with a rodA-yfp fusion gene (21) to study the spatiotemporal
localization of the elongation machinery following EMB treatment. In untreated cells,
RodA-yellow ﬂuorescent protein (YFP), representing the cell elongation machinery,
localized exclusively to the cell poles (Fig. 2E). As a control, we used a strain in which
the divisome-speciﬁc SEDS protein FtsW was replaced with the FtsW-cyan ﬂuorescent
protein (CFP) fusion protein. This fusion is also expressed at its native locus. As
predicted, in untreated cells, RodA localizes to cell poles while FtsW localizes to sites of
septation. Interestingly, upon EMB addition, RodA-YFP is mislocalized and no longer
spatially restricted to the cell poles (Fig. 2E); RodA-YFP localization resembled the
dispersed localization of DivIVA in EMB-treated cells. Previously, we have shown that
DivIVA recruits RodA to the cell poles via a direct protein-protein interaction (20, 21).
Hence, it is possible that EMB treatment induced a block of elongation growth and the
resulting mislocalization of DivIVA caused the displacement of the apical growth
machinery (elongasome). Consequently, apical growth is reduced and the cells adopt a
coccoidal morphology. This mislocalization of RodA is speciﬁc; EMB-treated cells still
exhibit the typical midcell localization of FtsW-CFP, indicating that the division ma-
chinery remains spatially conﬁned and is likely intact.
EMB treatment results in a stationary-phase-like morphotype. C. glutamicum
cells reduce apical growth during the stationary growth phase; the cell morphology of
stationary-phase cells is nearly coccoidal. Therefore, we sought to determine whether
the cell morphology and DivIVA accumulation levels observed in EMB-treated cells are
similar to those of stationary-phase cells. To this end, cells were grown to stationary
phase in BHI medium and subsequently treated with EMB. Indeed, we observed a
drastic increase in DivIVA-mCherry in stationary-phase cells (Fig. 2F) even in the
absence of EMB. Addition of EMB to stationary-phase cells did not alter cell length or
the DivIVA-mCherry concentration (as determined by mCherry ﬂuorescence; Fig. 2F).
Therefore, we conclude that EMB mimics stationary-phase conditions that lead to
increased DivIVA and halt apical elongation growth, hence resulting in morphological
changes.
EMB selectively affects apical cell wall synthesis. The observation that EMB
inhibition is restricted to exponentially growing cells (Fig. 2F) suggests that EMB only
affects the polar cell wall growth machinery. To test whether apical PG synthesis is
affected, we utilized a click-labeling approach in which PG-speciﬁc D-alanine is replaced
with azido-D-alanine, which is subsequently labeled with dyes by click chemistry (29).
Cells were grown in the presence of azido-D-alanine, which is incorporated into the
pentapeptide subunit of lipid II. Subsequent addition of reactive ﬂuorophores that bind
to the azido group allows the visualization of nascent PG. Untreated cells were stained
at the poles and septa, as previously demonstrated by vancomycin-FL staining (23, 30),
indicating polar cell wall synthesis. A strain expressing DivIVA-mCherry (DmC) was used
to show that PG incorporation colocalizes with sites of active PG synthesis (Fig. 3A).
Interestingly, azido-D-alanine labeling of EMB-treated cells revealed a complete absence
of polar cell wall synthesis. Instead, EMB-treated cells were only stained at their septa
(Fig. 3A). This observation indicates that polar PG synthesis is abolished following EMB
addition. To obtain more quantitative data, we developed an image analysis tool to
automatically analyze ﬂuorescence images. Morpholyzer NX is a Fiji (31)-based plug-in
that allows automated measurement of cell length and ﬂuorescence proﬁles along the
cell axis. The cells were then sorted according to their length (shortest cells on the left),
and data are presented as kymographs or animated GIF videos (see Movies S1 and S2).
Fluorescence intensities measured along the cell axis were plotted as heat maps.
Figure 3B shows the results of this automated image analysis for DivIVA-mCherry-
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expressing C. glutamicum cells (left side, cells without EMB treatment). The top, middle,
and bottom kymographs represent DivIVA-mCherry localization, azido-D-alanine label-
ing, and 2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DHPE) ﬂuorescence
distribution (representing MA distribution) (32), respectively. Bio-orthogonal labeling
FIG 3 EMB selectively blocks apical cell wall synthesis. (A) Sites of nascent PG in C. glutamicum cells (chromo-
somally encoding DivIVA-mCherry [red]) were labeled by strain-promoted azide-alkyne click chemistry. Azido-D-
alanine and DBCO-dye (DBCO-carboxyrhodamine 110 [green]) were added to growing cells (see Materials and
Methods) in the absence (EMB 0) or presence of 10 g · ml1 EMB (EMB 10). PG synthesis is visible at cell poles
and septa (white arrowheads). MA layers were stained with DHPE (yellow). In the presence of EMB, apical PG
synthesis is blocked and polar addition of MAs is lost (red arrowheads). (B) Automated image analysis of cell length
and ﬂuorescence distribution reveals the spatial localization of PG synthesis and MA distribution in the presence
or absence of EMB. The kymographs represent cells sorted by length (shortest cells on the left). Fluorescence
intensities are presented as heat maps (blue to yellow). Note the asymmetric ﬂuorescence staining of nascent PG
synthesis (azido-D-alanine) at the old cell pole. This coincides with an increased concentration of DivIVA-mCherry
at these poles (see Fig. 1 for more quantitative data). EMB causes polar loss of DHPE staining and signal
concentration along the side walls (n  400 for EMB 0; n  500 for EMB 10). Movies S1 and S2 are animated
GIF videos of all of the cells analyzed demonstrating the localization of DivIVA and PG synthesis.
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with azido-D-alanine is speciﬁc for nascent PG synthesis, while DHPE staining does not
discriminate between newly synthesized and old MAs. C. glutamicum cells appear to
grow asymmetrically with increased PG synthesis at one cell pole (Fig. 3B, middle).
Close inspection of the ﬂuorescence images indicated that the old cell pole gives rise
to rapid PG synthesis, while synthesis at the young cell pole is slower. The pole with
increased PG synthesis also exhibited an elevated DivIVA concentration (top), suggest-
ing that DivIVA assembly is directly linked to cell wall synthesis. Once the cells reached
a certain length, a new septum was formed, as indicated by DivIVA and azido-D-alanine
staining at the center of the cells. Importantly, new cell wall synthesis and DivIVA
overlap at the midcell position, indicating that DivIVA is spatially linked to cell wall
synthesis. DHPE staining was dispersed across the entire cell surface with no clear
enrichment at the cell poles, indicating that cells are completely surrounded by a MA
layer. In comparison with the situation in untreated cells, EMB addition drastically
altered the spatial localization of active cell wall synthesis. EMB-treated cells lacked
polar cell wall synthesis (Fig. 3B, middle). However, a strong staining pattern was
observed surrounding the midcell point at all cell lengths. These data show that cells
treated with EMB continue to divide and that cell wall synthesis is completely shifted
from the cell poles to the septum. The altered cell wall synthesis state is also reﬂected
by the change in DivIVA localization. In EMB-treated cells, DivIVA localization is reduced
at the cell poles and the apparent enrichment of DivIVA at the old cell pole is absent
(Fig. S4).
The divisome remains functional in the presence of EMB. Next, we wished to
determine whether EMB-treated cells are able to form new septa or whether the
observed presence of septal cell wall staining is due to septa initiated prior to EMB
treatment. We used a pulse-labeling approach to identify new division events in
EMB-treated cells. Cells were ﬁrst incubated with azido-D-alanine and then subse-
quently stained with dibenzocyclooctyne (DBCO)-carboxyrhodamine 110 (green). The
cells were then further cultivated in the presence of azido-D-alanine prior to the
addition of DBCO-Texas Red (red). These pulse-labeling experiments revealed that cells
tolerate the incorporation of azido-D-alanine and subsequent click labeling and con-
tinue to grow, indicating that azido-D-alanine incorporation is not toxic and does not
affect polar growth. Pulse-labeling of untreated cells clearly revealed the asymmetric
growth mode of C. glutamicum. The old cell pole consistently grew faster and synthe-
sized more cell wall material than the young pole (Fig. 4; Fig. S4). In addition, while
there was no apparent polar cell wall synthesis in EMB-treated cells, the formation of
new septa was visible. Newly formed septa were observed (red) following a second
FIG 4 EMB-treated cells synthesize new cell wall at division sites. Shown is pulse-labeling of PG synthesis
in C. glutamicum cells with azido-D-alanine and DBCO-carboxyrhodamine 110 (green ﬂuorescence) and
DBCO-Texas Red (red ﬂuorescence). Cells were pulsed ﬁrst with DBCO-carboxyrhodamine 110 and then
with DBCO-Texas Red. In the absence of EMB (EMB 0, top), cell wall synthesis originates at the cell poles
and new PG is transferred to the lateral walls. Note the asymmetric rates of PG synthesis at old and young
poles. The young pole is easily identiﬁable because of the characteristic V-shaped division in coryne-
bacteria. In the presence of EMB (EMB 10, 10 g · ml1), cell wall synthesis is blocked at the poles;
however, new division sites are initiated, as indicated by septal PG stained exclusively by DBCO-Texas
Red (bottom).
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labeling pulse (Fig. 4). The presence of newly formed septa in EMB-treated cells
indicates that the drug does not interfere with divisome function. Hence, the action of
EMB appears to be restricted solely to the polar-acting elongasome.
Although corynebacteria and mycobacteria have the same complex cell envelope
structure, we wanted to conﬁrm that EMB treatment blocks apical growth in members
of the genus Mycobacterium in a similar manner. We therefore pulse-labeled cell wall
synthesis in M. phlei in the presence or absence of EMB (10 g · ml1). Similar to
C. glutamicum, M. phlei cells synthesized cell wall PG from their cell poles and septa
(Fig. S5A). Upon treatment with EMB, apical cell wall synthesis was entirely blocked in
M. phlei, indicating that EMB treatment leads to selective blocking of apical growth in
mycobacteria as well. Automated image analysis revealed that untreated M. phlei cells
grow asymmetrically with both rapidly and slowly growing cell poles (Fig. S5B to D).
Following the addition of EMB to M. phlei cells, polar PG synthesis is lost and new cell
wall material is synthesized at the septum, similar to the situation in Corynebacterium.
Thus, we conclude that EMB treatment leads to the blockage of apical elongation
growth in different mycolata members.
Superresolution imaging of apical cell wall synthesis in the presence or ab-
sence of EMB. Conventional wide-ﬁeld imaging is diffraction limited, and hence, spatial
localization of proteins can only be estimated within a 250-nm range. We therefore
used photoactivated localization microscopy (PALM) to visualize the spatial distribution
of DivIVA and nascent PG synthesis with subdiffraction precision. The DBCO-carbo-
xyrhodamine 110 dye used for analysis of nascent cell wall synthesis possesses blinking
properties that are essential for localization microscopy (exact parameters are provided in
Materials and Methods). Cells with or without EMB treatment were grown in the presence
of azido-D-alanine and subsequently labeled with DBCO-carboxyrhodamine 110. The cells
were then ﬁxed and imaged with a 488-nm laser line. Nascent PG incorporation into
exponentially growing cells without EMB was found to localize (e.g., DBCO-carbo-
xyrhodamine 110 localization) primarily at the extreme cell poles (Fig. 5A). Additional cell
wall synthesis was concentrated at the site of septation. In contrast, in EMB-treated cells,
polar PG synthesis was nearly abolished, while septal PG synthesis was still present (Fig. 5B).
The sites of active cell wall synthesis coincide with DivIVA localization; therefore, we
analyzed DivIVA localization by superresolution microscopy. To do so, we ﬁrst constructed
a strain carrying a divIVA-mNeonGreen fusion gene at the native divIVA locus. The resulting
strain (GGCB1C8) produces only DivIVA-mNeonGreen. Growth, cell length, and DNA seg-
regation were unaffected in strain GGCB1C8, indicating that DivIVA-mNeonGreen is fully
functional (data not shown). Localization microscopy was performed with the 488-nm laser,
and as expected, DivIVA-mNeonGreen localized precisely to the cell poles and sites of
septation in untreated cells (Fig. 5C). Following EMB treatment, DivIVA localization is
dispersed into smaller foci and patches along the cell membrane without a clear polarity
axis (Fig. 5D), supporting the data obtained by wide-ﬁeld microscopy. These data indicate
that C. glutamicum cells grow through the insertion of PGmaterial at the extreme cell poles.
Importantly, this process is abolished following EMB treatment. Although DivIVA localiza-
tion is dispersed in EMB-treated cells, cell wall synthesis at the sites of division continues to
occur with high precision, indicating that the activity and placement of the divisome are
unaffected by EMB treatment.
EMB-treated cells have a compromised outer cell envelope. The apparent cell
wall synthetic activity of the divisome in the presence of EMB suggests that the cell wall
synthesized by the division machinery might not contain AG layers and, hence, not be
sensitive to EMB. Rather, the divisome might only synthesize PG, as observed in other
bacteria. To obtain a more detailed understanding of the surface structure of cells in the
presence or absence of EMB, we used scanning electron microscopy (SEM) imaging.
C. glutamicum cells grown in BHI without EMB exhibit a smooth homogeneous surface
(Fig. 6). A magniﬁed view of the poles of freshly divided daughter cells (Fig. 6a and b)
revealed a homogeneous cell surface at both the old (Fig. 6a) and new (Fig. 6b) cell
poles. In contrast, EMB-treated cells had a rough cell surface with uneven distribution
Ethambutol Selectively Blocks Apical Growth ®
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FIG 5 Superresolution imaging of cell wall synthesis and DivIVA localization. Shown are PALM images of PG synthesis in
C. glutamicum cells with azido-D-alanine stained with DBCO-carboxyrhodamine 110 (A, B) and cells expressing DivIVA-
mNeonGreen (strain GGCB1C8, C. glutamicum RES 167 divIVA::divIVA-mNeonGreen) (C, D) grown in the absence (A, C) or
presence (B, D) of EMB at 10 g · ml1. For each condition, a density rendering (a), a localization plot (b), an epiﬂuorescence
image (c), and a bright-ﬁeld image (d) are shown (scale bar, 500 nm). The newly synthesized cell wall in untreated cells (A)
localizes at the poles and at the septum. Similarly, DivIVA-mNeonGreen localizes to cell poles and active septa (C). In
EMB-treated cells, PG synthesis is shifted from the cell poles to the septum, suggesting a lack of or diminished polar growth
(B). EMB-treated cells exhibit partial loss of polarity, leading to DivIVA delocalization around the membrane (D).
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of outer material (Fig. 6c). Interestingly, the cell surface at the division sites seemed
rather smooth, indicating that the rough outer layer was no longer present at the new
division sites once the cells were treated with EMB (Fig. 6d). We hypothesized that the
material synthesized at the septum is PG without the mycolata-speciﬁc AG and MA
envelope layers. To test this hypothesis, we stained untreated and EMB-treated cells
with wheat germ agglutinin (WGA). WGA is a wheat lectin that binds to N-acetyl-D-
glucosamine. For ﬂuorescence imaging, the WGA was labeled with ﬂuorescein isothio-
cyanate (FITC). When untreated cells were incubated with WGA-FITC, only a diffuse,
weak ﬂuorescence signal was observed surrounding the entire cell surface (Fig. 6e). This
is likely due to the existence of a complete MA layer surrounding the cells. DHPE-
MarinaBlue labeling uniformly stained the entire cell surface, demonstrating that the
MA layer is shielding the entire cell surface. The DHPE-MarinaBlue staining patterns in
EMB-treated cells indicate that cell pole areas are devoid of (or have a reduced amount
of) MAs. WGA-FITC selectively labels the regions were the DHPE-MarinaBlue stain is
absent (Fig. 6f). These ﬁndings are in agreement with the hypothesis that the cell wall
material synthesized by the divisome consists primarily of PG, identiﬁed by the pres-
ence of N-acetyl-D-glucosamine, which is surface exposed in the presence of EMB. To
further corroborate the idea that PG is more exposed in cells treated with EMB, we
analyzed the susceptibility to lysozyme, an N-acetylmuramide glycanhydrolase known
to degrade the sugar backbone of PG. Indeed, cells treated with EMB are more sensitive
to lysozyme treatment than untreated cells are (Fig. S6).
EMB alters the composition of the cell wall. EMB inhibits the arabinosyltrans-
ferases EmbABC (C. glutamicum only encodes EmbC), thereby blocking polymerization
of the arabinose chains in the AG layer (18, 19). Terminal arabinose subunits are
covalently linked to MAs. Consequently, loss of arabinose polymers will result in
FIG 6 Loss of the outer cell envelope layer in C. glutamicum following EMB treatment. SEM images of
untreated C. glutamicum cells (EMB 0) reveal a smooth, continuous cell surface at old (a) and young (b)
cell poles, while cells treated with EMB (EMB 10, 10 g · ml1) show a rough cell surface at the lateral
sites and the old cell poles (c). Cells actively divide in the presence of EMB (d) and display a smooth,
homogeneous surface. (e) Staining with WGA-FITC (green) and DHPE-MarinaBlue (purple) reveals weak
uniform WGA staining in untreated cells. (f) In EMB-treated cells, WGA-FITC ﬂuorescence is enhanced at
the cell poles and septa, indicating increased binding of WGA-FITC to N-acetyl-D-glucosamine. These sites
coincide with the lack of the MA layer as determined by the absence of DHPE staining, suggesting that
PG constitutes the outer layer of the cell wall at dividing septa following EMB treatment.
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reduced levels of MA (33, 34). We therefore sought to determine the direct effects of
EMB treatment on cell wall composition. AG extracted from cells with and without EMB
treatment was hydrolyzed, and the resulting sugars were separated by thin-layer
chromatography (TLC) (Fig. 7A; Fig. S7). This analysis revealed that the arabinose
FIG 7 Loss of arabinose and MAs from the cell envelope of EMB-treated cells. (A) Analysis of the MA content of EMB-treated cells (red
column) and untreated control cells (blue column). Addition of EMB (10 g · ml1) leads to a drastic reduction of the MA content. MAMEs
were quantiﬁed by TLC (see Materials and Methods). (B) TLC analysis of AG sugars in the presence or absence of EMB. Sugars were
quantiﬁed in nanomoles per milligram of cell wall material. Note the speciﬁc reduction of arabinose following EMB treatment.
Transmission electron microscopy of untreated C. glutamicum cells reveals the multilayered cell envelope of CMN group bacteria. AG/PG,
AG/PG cell wall; MA, MA layer. Untreated cells have a smooth and even MA layer surrounding the cells (a, b). EMB-treated cells exhibit
a rough MA layer (c) that is selectively lost from cell poles (e).
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content of the EMB-treated cells was signiﬁcantly reduced to 10 to 20%, conﬁrming the
report that EMB targets arabinan synthesis (19). The galactose content was unchanged
(note that we identiﬁed 16% more galactose in the cell walls isolated after EMB
treatment), suggesting the presence of an intact galactan polymer (Fig. 7B). It is likely
that the galactan polymer is still covalently bound and thus remains part of the
complex cell wall sacculus.
To investigate whether alterations to cell wall composition have direct effects on cell
wall structure, we analyzed untreated and EMB-treated C. glutamicum cells by trans-
mission electron microscopy (Fig. 7). Untreated cells demonstrated a smooth and even
cell surface (Fig. 7a and b), conﬁrming the surface structure observed in the SEM
images. Close inspection of the SEM images allowed the identiﬁcation of the plasma
membrane (PM), the cell wall composed of PG and AG, and the outer layer of MAs. In
comparison, cells treated with EMB show a dispersed and frayed outer layer, likely
indicating the loss of MA layers (Fig. 7c to e). This observation agrees with the rough
outer layer observed in SEM images (Fig. 6) and the loss of hydrophobic material during
time-lapse imaging (Fig. 1; Fig. S1). Importantly, the selective loss of the outer cell
envelope layers from the cell poles (Fig. 7d and e, broken arrow) indicates that the cell
poles are the ﬁrst region to lose MA following the addition of EMB. These ﬁndings
support the DHPE staining results and indicate that the MA layer is assembled at the
poles.
EMB and -lactams act synergistically on Corynebacterium. Our data suggest
that EMB treatment selectively blocks apical cell growth and leads to loss of arabinose
and MAs from the cell envelope. However, cell division still occurs and the cells divide
with an apparently intact PG layer. Thus, we hypothesized that EMB treatment might
have synergistic effects with other antibiotics acting on PG synthesis. Therefore, we ﬁrst
determined the MICs of various antibiotics, such as penicillin G (PEN), carbenicillin
(CARB), rifampin (RIF), and EMB. To assess the putative additive or synergistic effects, we
used a checkerboard assay to study combinations of PEN, CARB, and RIF with EMB. The
RNA polymerase inhibitor RIF was used as a control because it does not target cell wall
synthesis. Furthermore, RIF is commonly used in TB treatment. Fractional inhibitory
concentrations (FICs) and FIC indices (FICs) were calculated according to Lechartier et
al. (35). As expected, the combination of RIF and EMB had an additive effect in the case
of C. glutamicum (FIC of 0.75). The combination of EMB with the -lactam drugs PEN
and CARB, however, showed a substantial increase in sensitivity. In the presence of
EMB, C. glutamicum has a FIC of 0.5 for CARB and 0.375 for PEN (Fig. 8A; Table 1).
These results suggest that combinations of -lactams with EMB act synergistically (FIC
of 0.5). Importantly, similar results were obtained with M. phlei (Fig. 8B; Table 2),
indicating that the synergistic effects of -lactams and EMB occur in general in
Corynebacterineae. It should be noted, however, that in this assay also the combination
of RIF and EMB had synergistic effects. The reason could be that the high concentra-
tions of -lactams necessary to reach the MIC lead to pleiotropic effects on the cells. As
already shown by increased sensitivity to lysozyme, these data once more support the
hypothesis that cells depleted of their MA layer and arabinose polymer sheet have
exposed cell wall PG, making them more sensitive to -lactam treatment.
DISCUSSION
Apical cell growth is a hallmark of bacteria belonging to the phylum Actinobacteria
(12, 36). However, it is still unclear how this apical growth machinery is assembled and
how it might differ from the machinery that synthesizes cell wall material during cell
division. In classical model organisms such as Escherichia coli and Bacillus subtilis, two
dedicated machineries are responsible for elongation growth (elongasome) and divi-
sion (divisome) (37). In Actinobacteria, the situation is less clear, although accumulating
evidence points to the existence of a dedicated elongasome and divisome (21, 27).
Corynebacterineae is a suborder within the phylum Actinobacteria that includes noto-
rious pathogens such as M. tuberculosis and C. diphtheriae. A unique feature of bacteria
in this suborder is that the mAGP complex constitutes the largest structure in the cell
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envelope (4, 5). mAGP integrity is essential for M. tuberculosis viability and infection.
However, it can be partially deleted from C. glutamicum. Therefore, C. glutamicum is an
ideal model system in which to study the inﬂuence of anti-TB drugs and their precise
mechanism on a single-cell level. Here, we have addressed the effect of EMB on cell
growth and morphology. EMB has been previously shown to affect the cell envelope
most likely by inhibiting the polymerization of cell wall arabinan (14, 18, 19, 28, 34).
Strains resistant to EMB often carry mutations in the arabinosyl transferases EmbABC
(18, 19). Deletion of the EMB-targeted arabinosyl transferase EmbC from C. glutamicum
leads to a truncated AG layer lacking the arabinose polymers and cell wall-bound
FIG 8 Synergistic effects of EMB and -lactam antibiotics detected with checkerboard REMA. C. glutamicum (A) and M. phlei (B) were
grown in microtiter plates with combinations of two antibiotics (added at 1:2 dilutions of the MIC). The ﬁrst horizontal and vertical rows
received only one antibiotic and served as the controls. Antibiotic concentrations are shown in micrograms per milliliter. Growth was
detected by checkerboard REMA. Heat maps of resoruﬁn ﬂuorescence values were prepared in R (mean values from two to ﬁve
experiments). (Top) REMA of a typical experiment. (Bottom) Heat maps of ﬂuorescence values.
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corynomycolates (34). Treatment with EMB was shown to mimic these phenotypes (34).
The loss of apical mycolates has been demonstrated with the MA-speciﬁc dye DHPE,
suggesting that the mycolate layer is added at the cell poles (32). Our data extend these
investigations and show that EMB treatment speciﬁcally blocks elongation growth. This
was demonstrated by a click-labeling approach to localize sites of active cell wall
synthesis by azido-D-alanine staining. Whereas untreated C. glutamicum and M. phlei
cells were stained at the poles and septa, EMB-treated cells were stained exclusively at
the septa. Interestingly, PG synthesis at the sites of division was not affected by EMB.
Using pulse-labeling experiments in which growing cells were labeled with azido-D-
alanine and subsequently modiﬁed with two ﬂuorescent dyes, we could show that PG
synthesis at the septum continues during EMB treatment and leads to the formation of
viable coccoidal cells that have a PG cell wall but lack most of the mycolyl-AG layer.
These data are consistent with the hypothesis that C. glutamicum and M. phlei have a
distinct elongasome that is exclusively inhibited by EMB and a divisome that is EMB
insensitive; this explains the bacteriostatic nature of EMB. Importantly, we could show
that the block in elongation growth caused by EMB mimics reduced cell elongation
during the stationary growth phase. We used DivIVA-mCherry accumulation as an
easy-to-follow marker of cell elongation and division (25). DivIVA is constitutively
expressed, and addition of EMB does not alter the transcription of the divIVA gene.
Under normal growth conditions, the level of DivIVA is diluted by growth and division.
However, in stationary-phase cells or following cell elongation blockage by EMB, DivIVA
accumulates and localizes randomly within the cells. DivIVA has been previously
demonstrated to be a key spatial organizer of the apical growth machinery via the
recruitment of RodA (20, 21) and mAGP complex synthesis proteins (27). In EMB-treated
cells, RodA is dispersed throughout the cells. The apparent mislocalization (or perhaps
disassembly) of the apical growth machinery explains the block of elongation growth.
In contrast, proteins of the divisome remain unchanged following EMB treatment, as
indicated by the localization of FtsW. Our data indicate that PG production is continued
by the cell division machinery in a coccoid-type manner. These data have two impor-
tant implications. It is tempting to speculate (i) that the elongasome synthesizes all
three cell wall layers (mAGP) in a large supercomplex while the divisome synthesizes
only PG and (ii) that treatment with EMB forces cells into stationary growth phase
behavior. In consequence, stationary-phase cells are not affected by EMB, as judged by
morphology or DivIVA-mCherry ﬂuorescence. The latter is an important factor when
considering antibiotic treatment regimens. In most cases, the best clearance of the
bacterial load is achieved when cells are actively dividing. M. tuberculosis, in particular,
is notorious for its long dormancy periods during which the bacteria are difﬁcult to treat
(38). Elongation growth appears to be nonessential for C. glutamicum viability. When
TABLE 1 Antibiotic sensitivity of C. glutamicum in the absence of EMB and interaction
proﬁle with a second antibiotic
Antibiotic MIC (g/ml)
Interaction proﬁle with EMB
FIC Outcome
PEN 0.5 0.375 Synergistic
CARB 8 0.5 Synergistic
RIF 0.004 0.75 Additive
TABLE 2 Antibiotic sensitivity of M. phlei in the absence of EMB and interaction proﬁle
with a second antibiotic
Antibiotic MIC (g/ml)
Interaction proﬁle with EMB
FIC Outcome
PEN 320 0.5 Synergistic
CARB 640 0.25 Synergistic
RIF 0.064 0.5 Synergistic
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polar elongation is blocked by EMB (or during stationary growth), the division machin-
ery is capable of providing PG synthesis that is sufﬁcient for viability. CMN group
bacteria exhibit a remarkable plasticity in response to drug treatment that allows the
adaption of these bacteria to survive antibiotic treatment directed against the mAGP
complex.
Pulse-labeling of growing cells with azido-D-alanine clearly revealed the asymmetric
growth of C. glutamicum. In all cells, the old pole synthesized consistently more PG than
the young pole. A simple explanation for this is that the elongation machinery needs
to assemble after cytokinesis and therefore the young pole lags behind; this young cell
pole then slowly matures until it reaches full synthesis capacity. We found that DivIVA
concentrations are higher at the fast-growing pole, in line with the role of DivIVA as a
scaffold for cell wall synthetic complexes. Following division, the new cell poles are in
a rebuilding phase in which the divisome is disassembled and an elongasome is built.
This phase leads to slowed elongation growth at the young pole until the elongasome
is fully assembled. Asymmetry in growth has been reported previously for M. tubercu-
losis and M. smegmatis (39, 40). This growth asymmetry, or more precisely the inheri-
tance of old poles, has been shown to inﬂuence antibiotic susceptibility (39). However,
this observation has been recently challenged (41); it has been suggested that the
difference in polar growth between the old and young poles is due not to pole age but
rather to the larger size of the old pole (42). Our data clearly show that inheritance plays
a role in the polar growth of C. glutamicum. We could show that the old pole usually
has a higher level of accumulated DivIVA protein, which in turn might recruit more cell
wall synthesis complexes to the cell pole. DivIVA accumulation is a time-dependent
process, and hence, the old poles have established a more active elongasome than the
young poles.
It has recently been proposed that cell wall synthesis in mycobacteria does not
occur precisely at the pole tip but rather is spatially conﬁned to subpolar regions (27).
Similar cell wall labeling experiments in this study revealed clear polar growth in
C. glutamicum cells by wide-ﬁeld microscopy (Fig. 3 to 4). Since wide-ﬁeld microscopy
is diffraction limited, we used localization microscopy to address the spatial localization
of nascent PG synthesis (visualized by azido-D-alanine staining) and DivIVA localization.
The DBCO-carboxyrhodamine 110 dye has blinking properties that can be exploited for
localization microscopy. Imaging data with a resolution of approximately 50 nm in the
x-y (the peak localization precision is 30 nm for DBCO-carboxyrhodamine 110 and
25 nm for DivIVA-mNeonGreen) direction indicate a clear enrichment of cell wall
synthesis at the extreme cell pole. This coincides with the region of DivIVA localization,
as shown by PALM imaging with DivIVA-mNeonGreen. Thus, in Corynebacterium, cell
wall synthesis appears to be polar and not subpolar, as previously reported for
mycobacteria (27). PALM imaging conﬁrms the loss of apical cell wall synthesis and the
mislocalization of DivIVA following EMB treatment. Apical growth (in comparison with
subapical cell wall synthesis zones) is compatible with previous ﬁndings showing a
direct protein-protein interaction between DivIVA and RodA. RodA was supposed to act
as a lipid II ﬂippase and may also regulate the activity of its cognate penicillin-binding
protein (20, 21). However, recent data suggest that RodA rather is a glycosyltransferase
involved in PG polymerization (24). It is currently unclear whether SEDS proteins such
as RodA and FtsW may act as ﬂippases and glycosyltransferases. The tight interaction
between RodA and DivIVA can also be inferred from the simultaneous mislocalization
of both proteins upon the addition of EMB. The EMB-caused blockage of cell elongation
and the associated mislocalization of excess DivIVA result in the recruitment of RodA by
DivIVA to artiﬁcial sites within the cell. Overexpression of DivIVA renders the cells more
susceptible to EMB, suggesting that the EMB-induced block of apical growth acts
through DivIVA. However, at present, we are unable to unambiguously distinguish
whether RodA and DivIVA mislocalization cause the blockage in elongation growth or
are a direct consequence thereof.
The emergence of multidrug-resistant (MDR) and extremely drug resistant M. tuber-
culosis strains has become a serious health threat and has initiated the search for new
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therapeutic strategies. These include revisiting the use of -lactam antibiotics (43, 44).
M. tuberculosis is resistant to most -lactams because of its impermeable outer mem-
brane; its potent, chromosomally encoded -lactamases; and the fact that a large
proportion of the cell wall PG is L,D cross-linked, a cell wall linkage that is insensitive to
-lactam antibiotics. However, combinatorial treatment with the -lactamase inhibitor
clavulanic acid and carbapenems has been shown to effectively decrease the bacterial
load in mouse models (45). The synergistic effects of -lactams in combination with
clavulanic acid and EMB on MDR strains have been previously shown (46–48). However,
within these studies, the underlying molecular reasons for the synergistic effect of EMB
and -lactams remained unclear. Here, we show that EMB effectively removes the outer
layers of the mAGP complex and that this, by blocking elongation growth, prohibits
new synthesis of these outer envelope layers. As cytokinesis seems to be virtually
unaffected by EMB, cell division creates a cell wall composed predominantly of exposed
PG, which is hence highly accessible to -lactam antibiotics. This notion is supported by
the increased lysozyme sensitivity of EMB-treated cells. Thus, simultaneous treatment
with EMB and -lactams does allow for the efﬁcient elimination of bacterial cells.
The results described here contribute to a more detailed understanding of elonga-
tion growth in CMN group bacteria and aid in our understanding of the molecular
action of EMB treatment. This adds to the ongoing and increased effort to improve
therapeutic procedures to cure TB or emerging NTM infections and may help to ﬁnd
suitable synergistic antibiotic combinations for effective treatments.
MATERIALS AND METHODS
Bacterial strains and cultivation. The strains used in this study are listed in Table S1. C. glutamicum
strains were grown in BHI medium (Oxoid). M. phlei was cultivated in DSMZ medium no. 219 (yeast
extract, 2.0 g; tryptically digested casein peptone, 2.0 g; Na2HPO4 · 12H2O, 2.5 g; KH2PO4, 1.0 g; Na citrate,
1.5 g; MgSO4 · 7H2O, 0.6 g; glycerol, 50 ml; Tween 80, 0.5 ml/liter [pH 7.0]). Prior to inoculation, 1‰ silicon
oil (a 1% suspension in water added to reduce surface tension and thus the clumping of cells) was added
to the medium. EMB was dissolved in water and added from stock solutions.
ConstructionofC. glutamicumRES167divIVA::divIVA-mNeonGreen. To generate plasmid pk19mobsacB-
divIVA-mNeonGreen-KI, which allows allelic replacement of divIVA with a divIVA C-terminally tagged with the
gene encoding mNeonGreen, an mNeonGreen fragment was ampliﬁed by PCR with primers SalI-
mNeonGreen-Fwd and mNeonGreen-TAA-XbaI-Rev (Table S1). The fragment obtained was digested with SalI
and XbaI and ligated into SalI- and XbaI-digested pCD191 (25). The resulting plasmid was then transformed
into C. glutamicum RES 167 to obtain RES 167 divIVA::divIVA-mNeonGreen.
Construction of C. glutamicum RES 167 pEKEX-divIVA-Dendra2. To construct a strain overexpress-
ing DivIVA-Dendra2, the divIVA gene was introduced into the IPTG-inducible pEKEX-2 vector (49) with
primers SalI RBS DivIVA forward and BamHI DivIVA reverse (Table S1). In frame with the divIVA gene we
cloned the gene for dendra2 with primers BamHI Dendra2 forward and SacI Dendra2 reverse (Table S1).
The constructed plasmid was transformed into C. glutamicum RES 167, giving strain GGB1C9 (Table S1).
qPCR. Cell cultures (5 ml) were harvested during the exponential growth phase (OD600 of ~3.0), and
cell pellets were stored at80°C. Stored pellets were resuspended in 350 l of RA1 buffer supplemented
with 3.5 l of -mercaptoethanol and lysed with a FastPrep homogenizer. RNA was isolated with the
NucleoSpin RNA kit (Macherey-Nagel) according to the manufacturer’s protocol. Synthesis of cDNA was
performed with the RevertAid H Minus First Strand cDNA synthesis kit (Thermo Scientiﬁc) with RevertAid
H Minus Moloney murine leukemia virus reverse transcriptase according to the manufacturer’s recom-
mendations. qPCR analysis to determine divIVA transcript levels was run in biological triplicate with three
housekeeping genes (thrC, glnA, and gyrB) as internal references. Primer efﬁciency assays were performed
to control for primer binding. All qPCR experiments were performed with KAPA SYBR Fast QPCR
MasterMix (Peqlab Biotechnologie GmbH).
Azido-D-alanine staining. Azido-D-alanine staining was performed as previously described (50). The
compounds used were obtained from Jena Bioscience. Cultures of C. glutamicum or C. glutamicum
DivIVA-mCherry were inoculated from overnight cultures to an OD600 of 0.2 and grown to an OD600 of
1 to 1.2. Next, 200-l aliquots were transferred to the wells of a microtiter plate and further incubated
in a ThermoMixer (Eppendorf) at 30°C and 850 rpm. Following 5 min of acclimatization, 1 l of
azido-D-alanine (1 M) (or 1 l D-alanine [1 M] for the controls) was added and the mixture was incubated
for 5 min (approximately 5% of the generation time). Cells were harvested, washed with phosphate-
buffered saline (PBS, pH 7.4), and resuspended in 200 l of PBS. Subsequently, 1 l of DBCO-ﬂuorophore
(carboxyrhodamine 110 or Texas Red at 1 mM in dimethyl sulfoxide) was added and the mixture was
incubated for 20 min at 30°C at 80 rpm in the dark. The cells were harvested and washed three times with
PBS containing 0.1% Tween 20 to effectively remove the unbound ﬂuorophore. Cells were then
resuspended in PBS for microscopy. For dual labeling, PBS and PBS–0.1% Tween 20 were replaced with
prewarmed BHI (30°C) following the ﬁrst labeling.
Live-dead staining. Viable cell counts were performed with the Bacteria Live/Dead Staining kit
(PromoKine) according to the manufacturer’s recommendations.
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Wide-ﬁeld microscopy. Wide-ﬁeld microscopy was performed on a Zeiss Axio Observer Z1 micro-
scope equipped with a Hamamatsu OrcaR2 camera and a Plan-Apochromat 100/1.4 oil Ph3 objective
(Zeiss). Fluorescence was visualized with the appropriate ﬁlter sets (Zeiss). An environmental chamber set
to 30°C was used for time-lapse studies. Images were acquired with ZEN (Zeiss) and processed with Fiji
(31). Final image assembly was conducted with Adobe Photoshop.
Localization microscopy. To prepare cells for PALM imaging, they where harvested and ﬁxed with
1% formaldehyde in PBS (1.78 g · liter1 Na2HPO4 · 2H2O, 1.42 g · liter1 Na2HPO4, 8 g · liter1 NaCl,
0.2 g · liter1 KCl, 0.27 2 g · liter1 KH2PO4 [pH 7.4]) for 20 min at 30°C on a shaker and washed three times
in PBS-G (PBS containing 10 mM glycine) to stop the reaction.
Prior to use, the imaging chambers (eight wells; Nunc) were cleaned by subsequent rounds of
sonication (20 min per step) with the following solutions: 0.1 M HCl, double-distilled H2O (ddH2O), 60%
ethanol, and ddH2O. Subsequent to sonication, the chambers were dried and plasma cleaned (15 mA for
30 s in a Cressington 208 Carbon High Vacuum Carbon Coater). To facilitate attachment of the ﬁxed cells,
0.1% poly-L-lysine (wt/vol) was added to the chambers and they were incubated for 1 h. The chambers
were then washed three times with PBS-G, and 1.5 to 2 l of a 1:1,000 dilution of TetraSpeck beads
(Thermo Fisher) was homogeneously distributed over the glass surface (the optimal concentration will
yield three to ﬁve beads per ﬁeld of view). The chamber was consecutively ﬁlled with PBS-G and ﬁxed
cells (the optimal concentration depends on the conditions and organism). The chamber was centrifuged
at 200  g to facilitate cell sedimentation and attachment to the glass surface.
A Zeiss ElyraP1 was used for PALM imaging (Alpha Plan-Apochromat 100/1.46 oil objective DIC
M27). The 488-nm laser and 495- to 550-nm bandpass and 750-nm low-pass ﬁlters were used for both
mNeonGreen and DBCO-carboxyrhodamine 110 imaging. For mNeonGreen, the parameters chosen were
50 ms with an electron-multiplying charge-coupled device (EMCCD) gain of 200 and 15% laser power.
DBCO-carboxyrhodamine 110 localization was imaged by using 100 ms with an EMCCD gain of 50 and
20% laser power. Imaging was performed under a pseudo-total internal reﬂection ﬂuorescence angle
with a sample penetration of approximately 400 nm (63.97°) for all the conditions except EMB-treated
RES 167 divIVA::divIVA-mNeonGreen; the background due to increased cell size and delocalized DivIVA
made HiLo a more suitable approach (100 ms, an EMCCD gain of 200, 15% laser power, and 47.26°). The
PALM images were calculated with the Zeiss ZenBlack software, and lateral drift was corrected by using
the ﬂuorescent beads as position references. Events originated by single molecules were then isolated
by ﬁltering for photon number (400 to 920). The resulting point spread function (PSF) distribution had
a Gaussian shape, suggesting that it originated from a single population. Further ﬁltering was used to
eliminate outliers (PSF, 100 to 200 nm; precision, 50 nm).
SEM. Samples for SEM were dropped onto a glass slide covered with a coverslip, shock frozen with
liquid nitrogen, and ﬁxed with 2.5% glutaraldehyde in ﬁxative buffer containing 25 mM cacodylate,
75 mM NaCl, and 2 mM MgCl2 (pH 7.0). The samples were washed with ﬁxative buffer, postﬁxed with 1%
OsO4 in ﬁxative buffer, and washed three times with the ﬁxative buffer, followed by ddH2O. The samples
were dehydrated with increasing concentrations of acetone and then critical-point dried with liquid CO2.
The samples were mounted on carbon stubs with conductive silver and sputtered with platinum (3 to
5 nm). High-resolution micrographs were taken with an Auriga scanning electron microscope (Zeiss).
Transmission electron microscopy. Samples for transmission electron microscopy were used to ﬁll
3-mm aluminum sandwich carriers, frozen at a high pressure (200 MPa) with an HPM 100 (Leica), freeze
substituted with 2% OsO4 and 0.2% uranyl acetate in acetone, and inﬁltrated with and embedded in
Spurr’s epoxy resin (ScienceServices). Following polymerization, ultrathin sections were cut with a
diamond knife with an UltraCut E ultra microtome (Reichert Jung). The ultrathin sections were post-
stained with lead acetate. Electron micrographs were taken with a Zeiss EM 912 transmission electron
microscope with an integrated Omega Filter operated in the zero-loss state.
AG preparation and analysis. SDS- and proteinase K-puriﬁed cell walls were prepared as previously
described (21). In brief, cells from 2-liter cultures were harvested in the early logarithmic phase and
disrupted with glass beads. The crude cell walls obtained were puriﬁed by consecutive SDS and
proteinase K treatments. The yield of pure cell walls normalized per OD unit was 1.3 times greater for
EMB-treated cells. AG was released from cell walls by incubation in 0.05 M H2SO4 (50 mg of puriﬁed cell
wall in 5 ml of H2SO4 for 4 days at 37°C). Extracted cell walls were pelleted (15 min at 3,000 g and 20°C).
Sulfuric acid was removed from the supernatant by precipitation with Ba(OH)2, and the supernatant was
dried in a SpeedVac. Sugars were liberated by mild acid hydrolysis (2 M HCl, 3 h, 100°C) and determined
and quantiﬁed by TLC performed on silica gel 60 plates (Merck) with two runs in an acetonitrile-water
(85:15, vol/vol) solvent system (51). Sugar visualization was performed with diphenylamine-aniline
(20 min 100°C). Signals were quantiﬁed with a Bio-Rad ChemiDoc System.
MA extraction and analysis. MA extraction was performed by a modiﬁed protocol previously
described (52). MA methyl esters (MAMEs) were extracted by acidic methanolysis. A 10-mg cell wall
sample was suspended in 600 l of dry methanol–toluene–95% sulfuric acid (30:15:1, vol/vol/vol) in glass
tubes with polytetraﬂuoroethylene-lined lids and incubated for 16 h at 50°C. After cooling to room
temperature, 400 l of petroleum ether (boiling point, 60 to 80°C) was added. Following mixing and
phase separation, the petroleum ether phase containing the MAMEs was removed and dried under a
nitrogen stream.
The dried sample was dissolved in 10 l of petroleum ether (60 to 80°C), and 1 l was used for TLC.
TLC was carried out on silica gel 60 plates (Merck). Plates were run once in toluene-acetone (97:3,
vol/vol). MAMEs were detected with molybdatophosphoric acid (3% in isopropanol, 20 min, 100°C).
Following development, the yellow background was bleached with ammonia vapor and the signals were
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quantiﬁed with the Bio-Rad ChemiDoc System. Since no standards for corynomycolates are available,
MAME levels could only be relatively compared.
Mycomembrane staining with MarinaBlue-DHPE. Cells were dried in a small spot on a microscope
slide in a stream of synthetic air and overlaid with 2 l of DHPE-MarinaBlue (Life Technologies, Inc.)
working solution (10 g · ml1 in methanol, freshly prepared from a 1-mg · ml1 stock solution in
ethanol-toluene [1:1, vol/vol]), and then dried again. Unbound dye was removed by rinsing with 500 l
of ﬁltered sterile water. Following drying, 5 l of bovine serum albumin (BSA; 10 mg · ml1) was applied
evenly over the cells and dried. For rehydration, the BSA-coated cells were covered with 1 l of water
and a large coverslip and analyzed by ﬂuorescence microscopy with the 4’,6-diamidino-2-phenylindole
(DAPI) channel (excitation wavelength, 358 nm; emission wavelength, 463 nm).
Lectin staining of PG with FITC-labeled WGA. Cells were spread on a glass slide and dried as
described for DHPE-MarinaBlue staining. Following heat ﬁxation, 10 l of FITC-WGA (1 mg · ml1 in PBS
[pH 7.4] containing 0.05% sodium azide; Sigma) was evenly distributed over the ﬁxed cells, and they were
incubated for 10 min in the dark. Next, the cells were rinsed three times with 500 l of ﬁltered sterile
water and then dried. For ﬂuorescence microscopy (green ﬂuorescent protein channel; excitation
wavelength, 489 nm; emission wavelength, 509 nm), cells were rehydrated with 1 l of water and
covered with a large coverslip.
For double staining of PG and mycomembrane, cells were ﬁrst labeled with FITC-WGA and subse-
quently stained with DHPE-MarinaBlue.
Detection of antibiotic interaction by checkerboard resazurin microtiter assay (REMA). The
antibiotic interaction assay was performed as described before (53). For C. glutamicum, 2-fold serial
dilutions of EMB starting at the MIC were prepared in 96-well microtiter plates in vertical or horizontal
rows (in four serial dilutions each; 100 l, calculated for 120 l). The antibiotics PEN, CARB, or RIF were
added in the opposite direction (1.2-l volumes of 100-fold stock solutions), starting at the respective
MICs. The ﬁrst vertical and horizontal rows served as negative controls.
An exponential-phase C. glutamicum culture was diluted to an OD600 of 0.001, and 20 l was added
to each well. The microtiter plate was incubated in a ThermoMixer at 30°C and 700 rpm for 16 h. A
20-l volume of resazurin (0.01% in distilled water, ﬁlter sterilized) was then added to each well, and
the plate was incubated in a ThermoMixer at 30°C and 300 rpm for 30 min. Tests were done in
parallel, both in a clear microtiter plate for visual inspection (no growth  no turnover of resazurin
[blue]; growth/viability  turnover to resoruﬁn [pink]) and in a black microtiter plate for ﬂuorescence
measurement. Fluorescence of resoruﬁn was recorded in a Tecan Inﬁnite M200 Pro (Tecan) micro-
plate reader (excitation wavelength, 560 nm; emission wavelength, 590 nm). Mean values calculated
from two to ﬁve experiments are shown in a heat map prepared with R.
For M. phlei, the checkerboard REMA was performed as described above, in BHI in 48-well plates in
a total volume of 250 l. An exponential-phase culture of M. phlei (grown in DSMZ medium no. 219) was
allowed to settle, and the supernatant with suspended cells without aggregates was used for inoculation.
This supernatant was diluted in BHI to an OD600 of 0.04, and 20 l was added to each well. Plates were
covered with Breathe-Easy sealing membrane (Sigma-Aldrich) and incubated in an orbital shaker at 37°C
and 250 rpm for 48 h. After removal of the sealing membrane, 20 l of resazurin (0.02% in distilled water,
ﬁlter sterilized) was added to each well. Plates were shaken for 30 min at 37°C and 80 rpm. After a picture
was taken, 120 l was transferred from each well into a black microtiter plate and ﬂuorescence was
recorded as described above. Heat maps were created as described above.
Computational image analysis. For the acquisition of data from the multichannel ﬂuorescent
images, a plug-in for the open-source image analysis platform Fiji was created (31). The algorithm
provides the possibility to analyze numerous images in an adequate timespan. The ﬁrst step is the
creation of a binary image from the phase-contrast channel by using the implemented function
AutoThreshold (default mode). Next, the outline of each cell is automatically detected with the wand
tool, yielding regions of interest covering all of the channels present. The algorithm developed uses the
maximal distance of each outline to determine the centerlines of single cells. Subsequently, perpendic-
ular lines reaching toward the cell outline are constructed along these centerlines. By determining the
center of the perpendicular lines, a more accurate centerline is created, reﬂecting the cell’s actual
curvature and length. A data set is created for each cell containing the length and the width along the
length (in micrometers), as well as the linear ﬂuorescence proﬁles of the centerlines and the correspond-
ing perpendicular lines. Evaluation and visualization of the data were performed with the statistical
open-source software R containing the default packages Hmisc and colorspace. The algorithm developed
was used to sort the cells by length and to translate the numeric data of the ﬂuorescence proﬁles
into a color code, providing channel-speciﬁc heat maps of the entire experiment obtained by
aligning the centerline proﬁles, as well as heat maps of single cells created by aligning the proﬁles
of the perpendicular lines. Videos were created by using the open-source software solutions FFmpeg
and ImageMagick.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mBio.02213-16.
FIG S1, TIF ﬁle, 0.1 MB.
FIG S2, TIF ﬁle, 0.9 MB.
FIG S3, TIF ﬁle, 6.8 MB.
FIG S4, TIF ﬁle, 0.7 MB.
Ethambutol Selectively Blocks Apical Growth ®
January/February 2017 Volume 8 Issue 1 e02213-16 mbio.asm.org 19
 o
n
 O
ctober 25, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
FIG S5, TIF ﬁle, 1.2 MB.
FIG S6, TIF ﬁle, 3.2 MB.
FIG S7, TIF ﬁle, 9.4 MB.
TABLE S1, DOCX ﬁle, 0.02 MB.
MOVIE S1, AVI ﬁle, 6.6 MB.
MOVIE S2, AVI ﬁle, 7.3 MB.
ACKNOWLEDGMENTS
We thank Silvia Dobler for assistance with electron microscopy and Nadine Albrecht
for technical support.
Funding from the German Federal Ministry of Education and Research (BMBF
031A302 e:Bio-Modul II: 0.6 plus) is kindly acknowledged.
REFERENCES
1. Horsburgh CR, Jr., Barry CE, III, Lange C. 2015. Treatment of tuberculosis.
N Engl J Med 373:2149–2160. https://doi.org/10.1056/NEJMra1413919.
2. Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Migliori
GB, Warren R. 2014. Global control of tuberculosis: from extensively
drug-resistant to untreatable tuberculosis. Lancet Respir Med 2:321–338.
https://doi.org/10.1016/S2213-2600(14)70031-1.
3. Gaur RL, Ren K, Blumenthal A, Bhamidi S, González-Nilo FD, Gibbs S,
Jackson M, Zare RN, Ehrt S, Ernst JD, Banaei N. 2014. LprG-mediated
surface expression of lipoarabinomannan is essential for virulence of
Mycobacterium tuberculosis. PLoS Pathog 10:e1004376. https://doi.org/
10.1371/journal.ppat.1004376.
4. Jankute M, Cox JA, Harrison J, Besra GS. 2015. Assembly of the myco-
bacterial cell wall. Annu Rev Microbiol 69:405–423. https://doi.org/
10.1146/annurev-micro-091014-104121.
5. Alderwick LJ, Harrison J, Lloyd GS, Birch HL. 2015. The mycobacterial cell
wall—peptidoglycan and arabinogalactan. Cold Spring Harb Perspect
Med 5:a021113. https://doi.org/10.1101/cshperspect.a021113.
6. Puech V, Chami M, Lemassu A, Lanéelle MA, Schifﬂer B, Gounon P, Bayan N,
Benz R, Daffé M. 2001. Structure of the cell envelope of corynebacteria:
importance of the non-covalently bound lipids in the formation of the cell
wall permeability barrier and fracture plane. Microbiology 147:1365–1382.
https://doi.org/10.1099/00221287-147-5-1365.
7. Burkovski A. 2013. Cell envelope of corynebacteria: structure and inﬂu-
ence on pathogenicity. ISRN Microbiol 2013:935736. https://doi.org/
10.1155/2013/935736.
8. McNeil M, Daffe M, Brennan PJ. 1990. Evidence for the nature of the link
between the arabinogalactan and peptidoglycan of mycobacterial cell
walls. J Biol Chem 265:18200–18206.
9. Bhamidi S, Scherman MS, Rithner CD, Prenni JE, Chatterjee D, Khoo KH,
McNeil MR. 2008. The identiﬁcation and location of succinyl residues and
the characterization of the interior arabinan region allow for a model of
the complete primary structure of Mycobacterium tuberculosis mycolyl
arabinogalactan. J Biol Chem 283:12992–13000. https://doi.org/10.1074/
jbc.M800222200.
10. Goodfellow M, Collins MD, Minnikin DE. 1976. Thin-layer chromato-
graphic analysis of mycolic acid and other long-chain components in
whole-organism methanolysates of coryneform and related taxa. J Gen
Microbiol 96:351–358. https://doi.org/10.1099/00221287-96-2-351.
11. Antoine I, Coene M, Cocito C. 1988. Size and homology of the genomes
of leprosy-derived corynebacteria, Mycobacterium leprae, and other
corynebacteria and mycobacteria. J Med Microbiol 27:45–50. https://
doi.org/10.1099/00222615-27-1-45.
12. Donovan C, Bramkamp M. 2014. Cell division in Corynebacterineae.
Front Microbiol 5:132. https://doi.org/10.3389/fmicb.2014.00132.
13. Kieser KJ, Baranowski C, Chao MC, Long JE, Sassetti CM, Waldor MK,
Sacchettini JC, Ioerger TR, Rubin EJ. 2015. Peptidoglycan synthesis in
Mycobacterium tuberculosis is organized into networks with varying
drug susceptibility. Proc Natl Acad Sci U S A 112:13087–13092. https://
doi.org/10.1073/pnas.1514135112.
14. Kilburn JO, Greenberg J. 1977. Effect of ethambutol on the viable cell
count in Mycobacterium smegmatis. Antimicrob Agents Chemother
11:534–540. https://doi.org/10.1128/AAC.11.3.534.
15. Ferebee SH, Doster BE, Murray FJ. 1966. Ethambutol: a substitute for para-
aminosalicylic acid in regimens for pulmonary tuberculosis. Ann N Y Acad
Sci 135:910–920. https://doi.org/10.1111/j.1749-6632.1966.tb45533.x.
16. Thomas JP, Baughn CO, Wilkinson RG, Shepherd RG. 1961. A new
synthetic compound with antituberculous activity in mice: ethambutol
(dextro-2,2=-(ethylenediimino)-di-L-butanol). Am Rev Respir Dis 83:
891–893. https://doi.org/10.1164/arrd.1961.83.6.891.
17. Brown-Elliott BA, Nash KA, Wallace RJ, Jr. 2012. Antimicrobial suscepti-
bility testing, drug resistance mechanisms, and therapy of infections
with nontuberculous mycobacteria. Clin Microbiol Rev 25:545–582.
https://doi.org/10.1128/CMR.05030-11.
18. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles
B, Musser JM, Jacobs WR, Jr. 1997. The emb operon, a gene cluster of
Mycobacterium tuberculosis involved in resistance to ethambutol. Nat
Med 3:567–570. https://doi.org/10.1038/nm0597-567.
19. Belanger AE, Besra GS, Ford ME, Mikusová K, Belisle JT, Brennan PJ,
Inamine JM. 1996. The embAB genes of Mycobacterium avium encode
an arabinosyl transferase involved in cell wall arabinan biosynthesis that
is the target for the antimycobacterial drug ethambutol. Proc Natl Acad
Sci U S A 93:11919–11924. https://doi.org/10.1073/pnas.93.21.11919.
20. Sieger B, Bramkamp M. 2014. Interaction sites of DivIVA and RodA from
Corynebacterium glutamicum. Front Microbiol 5:738. https://doi.org/
10.3389/fmicb.2014.00738.
21. Sieger B, Schubert K, Donovan C, Bramkamp M. 2013. The lipid II ﬂippase
RodA determines morphology and growth in Corynebacterium glutami-
cum. Mol Microbiol 90:966–982. https://doi.org/10.1111/mmi.12411.
22. Valbuena N, Letek M, Ordóñez E, Ayala J, Daniel RA, Gil JA, Mateos LM.
2007. Characterization of HMW-PBPs from the rod-shaped actinomycete
Corynebacterium glutamicum: peptidoglycan synthesis in cells lacking
actin-like cytoskeletal structures. Mol Microbiol 66:643–657. https://
doi.org/10.1111/j.1365-2958.2004.05943.x.
23. Letek M, Ordóñez E, Vaquera J, Margolin W, Flärdh K, Mateos LM, Gil JA.
2008. DivIVA is required for polar growth in the MreB-lacking rod-
shaped actinomycete Corynebacterium glutamicum. J Bacteriol 190:
3283–3292. https://doi.org/10.1128/JB.01934-07.
24. Meeske AJ, Riley EP, Robins WP, Uehara T, Mekalanos JJ, Kahne D, Walker
S, Kruse AC, Bernhardt TG, Rudner DZ. 2016. SEDS proteins are a
widespread family of bacterial cell wall polymerases. Nature 537:
634–638. https://doi.org/10.1038/nature19331.
25. Donovan C, Sieger B, Krämer R, Bramkamp M. 2012. A synthetic Esche-
richia coli system identiﬁes a conserved origin tethering factor in Acti-
nobacteria. Mol Microbiol 84:105–116. https://doi.org/10.1111/j.1365
-2958.2012.08011.x.
26. Lenarcic R, Halbedel S, Visser L, Shaw M, Wu LJ, Errington J, Marenduzzo
D, Hamoen LW. 2009. Localisation of DivIVA by targeting to negatively
curved membranes. EMBO J 28:2272–2282. https://doi.org/10.1038/
emboj.2009.129.
27. Meniche X, Otten R, Siegrist MS, Baer CE, Murphy KC, Bertozzi CR,
Sassetti CM. 2014. Subpolar addition of new cell wall is directed by
DivIVA in mycobacteria. Proc Natl Acad Sci U S A 111:E3243–E3251.
https://doi.org/10.1073/pnas.1402158111.
28. Radmacher E, Stansen KC, Besra GS, Alderwick LJ, Maughan WN, Hollweg
G, Sahm H, Wendisch VF, Eggeling L. 2005. Ethambutol, a cell wall
inhibitor of Mycobacterium tuberculosis, elicits L-glutamate efﬂux of
Schubert et al. ®
January/February 2017 Volume 8 Issue 1 e02213-16 mbio.asm.org 20
 o
n
 O
ctober 25, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
Corynebacterium glutamicum. Microbiology 151:1359–1368. https://
doi.org/10.1099/mic.0.27804-0.
29. Siegrist MS, Whiteside S, Jewett JC, Aditham A, Cava F, Bertozzi CR. 2013.
(D)-Amino acid chemical reporters reveal peptidoglycan dynamics of an
intracellular pathogen. ACS Chem Biol 8:500–505. https://doi.org/
10.1021/cb3004995.
30. Daniel RA, Errington J. 2003. Control of cell morphogenesis in bacteria:
two distinct ways to make a rod-shaped cell. Cell 113:767–776. https://
doi.org/10.1016/S0092-8674(03)00421-5.
31. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T,
Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ,
Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-
source platform for biological-image analysis. Nat Methods 9:676–682.
https://doi.org/10.1038/nmeth.2019.
32. Kumagai Y, Hirasawa T, Hayakawa K, Nagai K, Wachi M. 2005. Fluorescent
phospholipid analogs as microscopic probes for detection of the mycolic
acid-containing layer in Corynebacterium glutamicum: detecting alter-
ations in the mycolic acid-containing layer following ethambutol treat-
ment. Biosci Biotechnol Biochem 69:2051–2056. https://doi.org/10.1271/
bbb.69.2051.
33. Seidel M, Alderwick LJ, Birch HL, Sahm H, Eggeling L, Besra GS. 2007.
Identiﬁcation of a novel arabinofuranosyltransferase AftB involved in a
terminal step of cell wall arabinan biosynthesis in Corynebacterianeae [sic],
such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J
Biol Chem 282:14729–14740. https://doi.org/10.1074/jbc.M700271200.
34. Alderwick LJ, Radmacher E, Seidel M, Gande R, Hitchen PG, Morris HR,
Dell A, Sahm H, Eggeling L, Besra GS. 2005. Deletion of Cg-emb in
corynebacterianeae [sic] leads to a novel truncated cell wall arabinoga-
lactan, whereas inactivation of Cg-ubiA results in an arabinan-deﬁcient
mutant with a cell wall galactan core. J Biol Chem 280:32362–32371.
https://doi.org/10.1074/jbc.M506339200.
35. Lechartier B, Hartkoorn RC, Cole ST. 2012. In vitro combination studies of
benzothiazinone lead compound BTZ043 against Mycobacterium tuber-
culosis. Antimicrob Agents Chemother 56:5790–5793. https://doi.org/
10.1128/AAC.01476-12.
36. Flärdh K, Richards DM, Hempel AM, Howard M, Buttner MJ. 2012.
Regulation of apical growth and hyphal branching in Streptomyces. Curr
Opin Microbiol 15:737–743. https://doi.org/10.1016/j.mib.2012.10.012.
37. den Blaauwen T, de Pedro MA, Nguyen-Distèche M, Ayala JA. 2008.
Morphogenesis of rod-shaped sacculi. FEMS Microbiol Rev 32:321–344.
https://doi.org/10.1111/j.1574-6976.2007.00090.x.
38. Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I,
McHugh TD, Schito M, Maeurer M, Nunn AJ. 2014. New antituberculosis
drugs, regimens, and adjunct therapies: needs, advances, and future
prospects. Lancet Infect Dis 14:327–340. https://doi.org/10.1016/S1473
-3099(13)70328-1.
39. Aldridge BB, Fernandez-Suarez M, Heller D, Ambravaneswaran V, Irimia
D, Toner M, Fortune SM. 2012. Asymmetry and aging of mycobacterial
cells lead to variable growth and antibiotic susceptibility. Science 335:
100–104. https://doi.org/10.1126/science.1216166.
40. Singh B, Nitharwal RG, Ramesh M, Pettersson BM, Kirsebom LA, Das-
gupta S. 2013. Asymmetric growth and division in Mycobacterium spp.:
compensatory mechanisms for non-medial septa. Mol Microbiol 88:
64–76. https://doi.org/10.1111/mmi.12169.
41. Wakamoto Y, Dhar N, Chait R, Schneider K, Signorino-Gelo F, Leibler S,
McKinney JD. 2013. Dynamic persistence of antibiotic-stressed myco-
bacteria. Science 339:91–95. https://doi.org/10.1126/science.1229858.
42. Santi I, Dhar N, Bousbaine D, Wakamoto Y, McKinney JD. 2013. Single-cell
dynamics of the chromosome replication and cell division cycles in myco-
bacteria. Nat Commun 4:2470. https://doi.org/10.1038/ncomms3470.
43. Fisher JF, Mobashery S. 2016. Beta-lactam resistance mechanisms: Gram-
positive bacteria and Mycobacterium tuberculosis. Cold Spring Harb
Perspect Med 6. https://doi.org/10.1101/cshperspect.a025221.
44. Wivagg CN, Bhattacharyya RP, Hung DT. 2014. Mechanisms of -lactam
killing and resistance in the context of Mycobacterium tuberculosis. J
Antibiot (Tokyo) 67:645–654. https://doi.org/10.1038/ja.2014.94.
45. England K, Boshoff HI, Arora K, Weiner D, Dayao E, Schimel D, Via LE,
Barry CE, III. 2012. Meropenem-clavulanic acid shows activity against
Mycobacterium tuberculosis in vivo. Antimicrob Agents Chemother 56:
3384–3387. https://doi.org/10.1128/AAC.05690-11.
46. Abate G, Miörner H. 1998. Susceptibility of multidrug-resistant strains of
Mycobacterium tuberculosis to amoxicillin [sic] in combination with
clavulanic acid and ethambutol. J Antimicrob Chemother 42:735–740.
https://doi.org/10.1093/jac/42.6.735.
47. Hoffner SE, Källenius G, Beezer AE, Svenson SB. 1989. Studies on the
mechanisms of the synergistic effects of ethambutol and other antibac-
terial drugs on Mycobacterium avium complex. Acta Leprol 7(Suppl
1):195–199.
48. Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Källenius G. 1989.
In-vitro synergistic activity between ethambutol and ﬂuorinated quino-
lones against Mycobacterium avium complex. J Antimicrob Chemother
24:317–324. https://doi.org/10.1093/jac/24.3.317.
49. Eikmanns BJ, Kleinertz E, Liebl W, Sahm H. 1991. A family of Corynebac-
terium glutamicum/Escherichia coli shuttle vectors for cloning, con-
trolled gene expression, and promoter probing. Gene 102:93–98. https://
doi.org/10.1016/0378-1119(91)90545-M.
50. Kolb HC, Finn MG, Sharpless KB. 2001. Click chemistry: diverse chemical
function from a few good reactions. Angew Chem Int Ed Engl 40:
2004–2021.
51. Gauch R, Leuenberger U, Baumgartner E. 1979. Rapid and simple determi-
nation of aﬂatoxin M1 in milk in the low parts per 10(12) range. J Chro-
matogr 178:543–549. https://doi.org/10.1016/S0021-9673(00)92513-5.
52. Minnikin DE, Alshamaony L, Goodfellow M. 1975. Differentiation of
Mycobacterium, Nocardia, and related taxa by thin-layer chromato-
graphic analysis of whole-organism methanolysates. J Gen Microbiol
88:200–204. https://doi.org/10.1099/00221287-88-1-200.
53. Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. 2002.
Resazurin microtiter assay plate: simple and inexpensive method for detec-
tion of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents
Chemother 46:2720 –2722. https://doi.org/10.1128/AAC.46.8.2720
-2722.2002.
Ethambutol Selectively Blocks Apical Growth ®
January/February 2017 Volume 8 Issue 1 e02213-16 mbio.asm.org 21
 o
n
 O
ctober 25, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
